Skip to main content
Numero verde Huntington
info@lirh.it
| Toll-free number
800 388 330
800 388 330
EN
Toggle Dropdown
EN
IT
Huntington's Disease
What is HD
Symptoms of Huntington’s Disease
How to treat the disease
Genetic testing
Huntington e genitorialità
Huntington’s Disease in children
History of Huntington’s Disease
HD Patient Journey
Italian White Paper on Huntington's Disease
Huntington's Disease management model
Who we are
LIRH Foundation
Our people
Our network
Our Team
What we do
Research
Care
Awareness
Annual Conference
Progetto S.M.A.R.T.
Get involved
Make a Donation
5xmille
Participate
Become a member
Solidary favors
Corporate donations
Clinical Trials
Why participate
Testimonies
News & media
Latest news
Events
Video
Webinar
Huntington Post
Media Kit
Documenti utili
Contacts
Where to find us
Questions and answers
Ask to expert
Get in touch
Careers
Menu
Home
Latest news
SIGNAL trial: pepinemab does not affect Huntington disease's symptoms
Conect4children: A network for European clinical trials for children
Huntington's disease: evidence of altered brain development even before birth
The first Epidemiological study on Huntington in the Middle East makes the rethinking of the global number of people affected by HD necessary
The origin of Huntington Disease in the Middle East described for the very first time: Why this is relevant for possible future treatments
UniQure Announces First Two Patients Treated in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
Let's meet Pantaleone Megna, director of the "The Shape of Life"
A new hope for a cure: pridopidine will return to a experimental phase
What we learnt by providing assistance to Huntington families during the Coronavirus’ emergency
#ShowUpForHD: Huntington disease has many faces, what's yours?
Huntington e COVID-19: the LIRH's Foundation survey to measure the impact of the emergency on the families involved
Huntington disease: the disregarded recommendations on the use of neuroleptic drugs
How to cope with Coronavirus' restrictions. Psychologists’ advice for Huntington's disease and every families
Webinar: Huntington disease and Coronavirus- a difficult combination
Having the same disease doesn't mean to be the same patient: towards an era of personalized medicine
Huntington and Coronavirus (responsible for the COVID-19 syndrome)
Despite Coronavirus, the assistance to Huntington patients is guaranteed
Huntington’s Disease: the thin scary border among the need to disclose a genetic risk, the right to know and the duty to protect privacy
New treatments for the cure of Huntington's disease: launch of the telemedicine European project.
How a LIRH outpatients clinic works: a day in Campi Bisenzio (Florence)
New Updates on the Generation HD1 study - 14 10 2019
Stronger Together, Better Together: EHA Conference 2019
HD families from Puglia Region met in Bari on September 8, 2019
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Current page
3
Page
4
Next page
››
Last page
Last »
Everything is possible, if we are many!
DONATE
GET INVOLVED
5x1000
1
1
Huntington's Disease
What is HD
Symptoms of Huntington’s Disease
How to treat the disease
Genetic testing
Huntington e genitorialità
Huntington’s Disease in children
History of Huntington’s Disease
HD Patient Journey
Italian White Paper on Huntington's Disease
Huntington's Disease management model
Who we are
LIRH Foundation
Our people
Our network
Our Team
What we do
Research
Care
Awareness
Annual Conference
Progetto S.M.A.R.T.
Get involved
Make a Donation
5xmille
Participate
Become a member
Solidary favors
Corporate donations
Clinical Trials
Why participate
Testimonies
News & media
Latest news
Events
Video
Webinar
Huntington Post
Media Kit
Documenti utili
Contacts
Where to find us
Questions and answers
Ask to expert
Get in touch
Careers